← Back to Search

Procedure

Sonopet ultrasonic saw for Broken Bones

N/A
Waitlist Available
Led By Sohail Saghezchi, DDS, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months postoperatively
Awards & highlights

Study Summary

This trialwill study postoperative paresthesias in patients undergoing BSSO surgery using an ultrasonic or reciprocating saw to compare effects.

Eligible Conditions
  • Broken Bones
  • Nerve Injury
  • Paresthesia
  • Surgical Complications
  • Nerve Entrapment
  • Mandibular Nerve Injury
  • Micrognathia
  • Recessed Chin
  • Mandibular Prognathism
  • Overbite

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months postoperatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months postoperatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Postoperative hypoesthesia

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Sonopet ultrasonic sawActive Control1 Intervention
This instrument is being compared to the reciprocating saw
Group II: Reciprocating sawPlacebo Group1 Intervention
The traditional surgical instrument used for cutting bilateral sagittal split osteotomies

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,512 Total Patients Enrolled
Sohail Saghezchi, DDS, MDPrincipal InvestigatorUC San Francisco

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any additional opportunities for participation in this research?

"The clinicaltrials.gov page conveys that recruitment for this medical trial has been suspended since October 12th 2022, when the listing was last updated. Despite not actively seeking participants at present, there are an abundance of alternate studies looking to enrol patients right now - up to 1,248 in total."

Answered by AI
~11 spots leftby Apr 2025